Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Juliet Compston
96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study
Antiviral Therapy
Infectious Diseases
Pharmacology
Use of FTIR Spectroscopic Imaging to Identify Parameters Associated With Fragility Fracture
Journal of Bone and Mineral Research
Endocrinology
Orthopedics
Sports Medicine
Metabolism
Diabetes
Related publications
Abacavir–Lamivudine Versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
New England Journal of Medicine
Medicine
Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
First-Line Antiretroviral Therapy With Efavirenz Plus Tenofovir Disiproxil Fumarate/Emtricitabine or Rilpivirine Plus Tenofovir Disiproxil Fumarate/Emtricitabine: A Durability Comparison
HIV Medicine
Health Policy
Infectious Diseases
Pharmacology
Early Markers of Tubular Dysfunction in Antiretroviral-Experienced HIV-Infected Patients Treated With Tenofovir Versus Abacavir
AIDS Patient Care and STDs
Environmental
Public Health
Infectious Diseases
Occupational Health
Differential Effects of Tenofovir/Emtricitabine and Abacavir/Lamivudine on Human Leukocyte Recruitment
Antiviral Therapy
Infectious Diseases
Pharmacology
Patient-Reported Symptoms on the Antiretroviral Regimen Efavirenz/Emtricitabine/Tenofovir
AIDS Patient Care and STDs
Environmental
Public Health
Infectious Diseases
Occupational Health
Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Effects of Highly Active Antiretroviral Therapy on Platelet Activating Factor Metabolism in Naïve HIV-Infected Patients: II) Study of the Abacavir/Lamivudine/Efavirenz Haart Regimen
International Journal of Immunopathology and Pharmacology
Allergy
Immunology
Pharmacology
In Vitro Human Immunodeficiency Virus Type 1 Resistance Selections With Combinations of Tenofovir and Emtricitabine or Abacavir and Lamivudine
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology